The Board of Directors of Roivant Sciences Ltd. has authorized a buyback plan on April 2, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.73 USD | -1.20% | -0.92% | -4.45% |
May. 30 | Roivant Sciences Ltd. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
May. 30 | Transcript : Roivant Sciences Ltd., Q4 2024 Earnings Call, May 30, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.45% | 8.02B | |
+42.83% | 748B | |
+34.11% | 598B | |
-5.70% | 356B | |
+18.06% | 325B | |
+4.63% | 283B | |
+17.02% | 245B | |
+9.26% | 211B | |
-4.21% | 209B | |
+2.43% | 166B |
- Stock Market
- Equities
- ROIV Stock
- News Roivant Sciences Ltd.
- Roivant Sciences Ltd. authorizes a Buyback Plan.